Discontinued ProductAceclidine hydrochloride (Cat. No. 0689) has been withdrawn from sale for commercial reasons.
Cholinergic muscarinic agonist, cholinesterase inhibitor, hypotensive.
|Storage||Store at RT|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
References are publications that support the biological activity of the product.
Ehlert et al (1996) The interaction of the enantiomers of aceclidine with subtypes of the muscarinic receptor. J.Pharmacol.Exp.Ther. 279 1335 PMID: 8968358
Etze et al (1993) Characterization of muscarinic receptors mediating vasodilation in rat perfused kidney. Eur.J.Pharmacol. 238 343 PMID: 8405103
Ringdahl et al (1982) Muscarinic activity and receptor binding of the enantiomers of aceclidine and its methiodide. Mol.Pharmacol. 21 594 PMID: 6125875
View Related Products by Product Action
Keywords: Aceclidine hydrochloride, Aceclidine hydrochloride supplier, Cholinergic, muscarinic, agonist, cholinesterase, inhibitors, inhibits, hypotensive, Non-selective, Muscarinics, 0689, Tocris Bioscience
Citations for Aceclidine hydrochloride
Citations are publications that use Tocris products.
Currently there are no citations for Aceclidine hydrochloride.
Reviews for Aceclidine hydrochloride
There are currently no reviews for this product. Be the first to review Aceclidine hydrochloride and earn rewards!
Have you used Aceclidine hydrochloride?
Submit a review and receive an Amazon gift card.
$10US/$10CAN/€7/£6 gift card for a review without an image
$25US/$25CAN/€18/£15 gift card for a review with an image
*Offer only valid in the USA / Canada, UK and EuropeSubmit a Review
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* or download your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Alzheimer's disease (AD) is a degenerative brain disease and the most common cause of dementia, affecting approximately 47 million people worldwide. Updated in 2015, this poster summarizes the structural and functional changes observed in the progression of this neurodegenerative disease, as well as classic AD drug targets.
Learning & Memory Poster
Recognition memory enables us to make judgements about whether or not we have encountered a particular stimulus before. This poster outlines the cellular mechanisms underlying recognition memory and its links to long-term depression, as well as the use of pharmacological intervention to assess the role of neurotransmitters in recognition memory.
Schizophrenia is a debilitating psychiatric disorder that affects 1% of the worldwide population. This poster describes the neurobiology of Schizophrenia, as well as highlighting the genetic and environmental factors that play a fundamental role in the etiology of the disease. The current and emerging drug targets are also discussed.